Astrazeneca Plc
Held by 3 superinvestors (AZN).
Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.
Ownership · 13F consensus
Who's buying it
Institutional ownership aggregated across funds — consensus strength and this quarter's moves. Describes actions, not advice.
3 superinvestors hold it · $1.45B combined
Largest holder Sarah Ketterer
Held by 3 superinvestors of Astrazeneca Plc (AZN); this quarter 3 opened (as of 2026-03-31).
13F positions are self-reported and can lag up to 45 days. Informational only — not investment advice.
Superinvestors Holding This Security
- Value$1.44BWeight (prev→now)New · 17.7%
- Value$11.3MWeight (prev→now)New · 0.0%
- Value$5.1MWeight (prev→now)New · 0.0%
Ownership overview
Astrazeneca Plc (AZN) is held by 3 of the superinvestors tracked on Compounder, with a combined $1.45B in reported 13F value. The largest position belongs to Sarah Ketterer, where it makes up 17.7% of the portfolio.
Other notable holders by value include Dodge & Cox (0.0% of its book) and Polen Capital (0.0% of its book).
Over the latest quarter, 3 of the tracked filers opened a new position in AZN, 0 added to existing ones, 0 trimmed, and 0 sold out entirely.
Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-03-31. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.
Sources· SEC EDGAR 13F as of 2026-05-14
Stay Updated
Curated 13F moves and valuation insights, straight to your inbox.